CDK Inhibitors-Cell Cycle Arrest Versus Apoptosis

被引：34
作者：
Schwartz, Gary K. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Lab New Drug Dev & Gastrointestinal Canc, 1275 York Ave, New York, NY 10021 USA
来源：
CELL CYCLE | 2002年 / 1卷 / 02期
关键词：
D O I：
10.4161/cc.1.2.112
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：122 / +
页数：2
相关论文
共 23 条
  • [1] Bible KC, 1996, CANCER RES, V56, P4856
  • [2] Bible KC, 1997, CANCER RES, V57, P3375
  • [3] Carlson B, 1999, CANCER RES, V59, P4634
  • [4] Carlson BA, 1996, CANCER RES, V56, P2973
  • [5] Flavopiridol inhibits P-TEFb and blocks HIV-1 replication
    Chao, SH
    Fujinaga, K
    Marion, JE
    Taube, R
    Sausville, EA
    Senderowicz, AM
    Peterlin, BM
    Price, DH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) : 28345 - 28348
  • [6] Induction of Apoptosis in Human Leukemia Cells by the CDK1 Inhibitor CGP74514A
    Dai, Yun
    Dent, Paul
    Grant, Steven
    [J]. CELL CYCLE, 2002, 1 (02) : 143 - 152
  • [7] The cyclin-dependent kinase inhibitor flavopiridol induces apoptosis in human leukemia cells (U937) through the mitochondrial rather than the receptor-mediated pathway
    Decker, RH
    Dai, Y
    Grant, S
    [J]. CELL DEATH AND DIFFERENTIATION, 2001, 8 (07) : 715 - 724
  • [8] GRANA X, 1995, ONCOGENE, V11, P211
  • [9] Cyclins and cell cycle checkpoints
    Johnson, DG
    Walker, CL
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 295 - 312
  • [10] Jung C, 2001, CLIN CANCER RES, V7, P2537
123